Healthways, Hawaiian health insurer restructure, extend deal

8% of local company's employees will transfer to client's payroll
Sep 15, 2015 2:25 PM

Former Healthways COO wants $3M+ over firing

Michela says he was served papers after saying he wouldn't wait in line behind CEO-to-be Tramuto
Aug 25, 2015 7:03 AM

Healthways sends COO packing

Exec on second stint with company was named to post year ago
Aug 20, 2015 7:54 AM

Healthways stays close to home for new CEO

Chairman preps move into corner office, is in line for $1.25M cash award
Aug 7, 2015 7:27 AM

Hedge fund declares big Healthways stake

Firm becomes seventh owner of at least 5%
Jul 30, 2015 11:48 AM

Earnings wrap: Healthways, Sitel

Population health management company surprises with profit; currency swings limit call center owner gains
Jul 24, 2015 6:48 AM

Analyst action: Healthways, Acadia

Two longtime Healthways analysts on Friday cut their price targets for the population health management play after new and interim CEO Alfred Lumsdaine said 2015 profits will not meet expectations. But both Brooks O'Neil at Dougherty and Sean Wieland at Piper Jaffray are not telling investors to stop buying the company's shares, keeping Healthways at 'buy' and 'overweight' ratings, respectively. O'Neil's target for Healthways, which on Friday fell 20 percent to $12.40 (Ticker: HWAY), has come all the way down to $15 from $25. Wieland is staying more upbeat: His target now stands at $25.50, down from $27.

The skies are decidedly brighter for shareholders of Acadia Healthcare, which has climbed about 25 percent so far in 2015 after rising by about a third last year. Mizuho Securities analysts see even better days ahead and have launched coverage of the Franklin-based company with an 'outperform' rating at a price target of $84. Acadia (Ticker: ACHC) closed Friday trading at $76.47.

Jun 22, 2015 7:19 AM

Healthways cuts guidance, shares hammered

Lower revenues, slower biz development leads to expected $20M EBITDA drop
Jun 19, 2015 7:03 AM

Analyst action: Community Healthcare Trust, Healthways

Analyst Steve Manaker at Oppenheimer has launched coverage of newly public Community Healthcare Trust with an 'outperform' rating and a price target of $21. A key in his analysis is the type of properties CEO Tim Wallace and his team are targeting: "The key for us is not just management's ability to underwrite the real estate but also the importance of a tenant's place in the local healthcare ecosystem." Community Healthcare Trust (Ticker: CHCT) is changing hands this morning at about $19.10.

Manaker's colleague Mohan Naidu has begun covering shares of population health management company Healthways (Ticker: HWAY) with a neutral rating. Among his concerns are how the exit of former CEO Ben Leedle might hurt contract renewals and the long-term impact of health insurance exchanges on Healthways' work with large employers.

Jun 18, 2015 10:42 AM

Healthways snags big French renewal

Disease management partnership began in 2011
Jun 4, 2015 2:51 PM